Zannoni, Gian Franco
 Distribuzione geografica
Continente #
NA - Nord America 7.338
EU - Europa 7.058
AS - Asia 3.550
SA - Sud America 748
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 18.904
Nazione #
US - Stati Uniti d'America 7.266
DE - Germania 1.888
SE - Svezia 1.508
SG - Singapore 1.264
CN - Cina 1.178
IT - Italia 1.134
BR - Brasile 682
UA - Ucraina 485
FR - Francia 461
IE - Irlanda 446
IN - India 354
ID - Indonesia 269
GB - Regno Unito 253
FI - Finlandia 204
PL - Polonia 195
RU - Federazione Russa 163
CI - Costa d'Avorio 139
TR - Turchia 131
NL - Olanda 78
HK - Hong Kong 71
KR - Corea 55
AT - Austria 49
BE - Belgio 49
CA - Canada 43
VN - Vietnam 34
IR - Iran 32
JP - Giappone 29
AR - Argentina 23
CZ - Repubblica Ceca 18
IQ - Iraq 18
MX - Messico 17
RO - Romania 17
CH - Svizzera 15
LT - Lituania 15
BD - Bangladesh 13
ES - Italia 13
CL - Cile 11
EC - Ecuador 11
MA - Marocco 11
EG - Egitto 10
IL - Israele 10
PH - Filippine 10
OM - Oman 9
PE - Perù 9
UZ - Uzbekistan 9
AU - Australia 8
PK - Pakistan 8
PT - Portogallo 8
ZA - Sudafrica 8
AZ - Azerbaigian 7
HU - Ungheria 7
EU - Europa 6
KE - Kenya 6
KG - Kirghizistan 6
LV - Lettonia 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
MD - Moldavia 5
NO - Norvegia 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
GR - Grecia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
AL - Albania 3
BG - Bulgaria 3
CO - Colombia 3
JO - Giordania 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MK - Macedonia 3
NP - Nepal 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
Totale 18.892
Città #
Chandler 1.814
Singapore 731
Ashburn 554
Dublin 441
Jacksonville 354
San Mateo 301
Jakarta 268
New York 240
Rome 206
Wilmington 205
Nanjing 194
Boston 190
Ann Arbor 182
Hyderabad 173
Milan 164
Dearborn 162
Warsaw 162
Princeton 149
Abidjan 139
Los Angeles 118
Beijing 108
Moscow 106
Marseille 105
Fairfield 101
Houston 101
Cattolica 100
Izmir 97
The Dalles 97
Woodbridge 94
Frankfurt am Main 85
Helsinki 84
Seattle 84
Lawrence 80
Nürnberg 80
Redwood City 74
Munich 72
Hefei 69
Nanchang 69
São Paulo 61
Bremen 59
Hong Kong 57
Seoul 53
Brussels 47
Zhengzhou 46
Redmond 44
Boardman 43
Hangzhou 42
Norwalk 42
Düsseldorf 35
Hebei 34
Lancaster 34
Cambridge 33
Changsha 33
Tianjin 32
Jiaxing 31
Shenyang 31
Augusta 30
Falkenstein 29
Mountain View 29
Kunming 28
Leawood 28
Vienna 28
University Park 27
London 26
Nuremberg 25
Lauterbourg 24
Toronto 24
Chicago 23
Paris 23
Busto Arsizio 21
Fremont 21
Washington 21
Pune 20
Santa Clara 20
Kraków 19
Shanghai 19
Andover 18
Guangzhou 18
Bexley 17
Rio de Janeiro 17
Belo Horizonte 16
Brasília 16
Jinan 16
Tokyo 16
San Francisco 15
Bari 14
Brooklyn 13
Curitiba 13
Portsmouth 13
Turku 13
Amsterdam 12
Detroit 12
Kish 12
Lappeenranta 12
Roubaix 12
Atlanta 11
Changchun 11
Edinburgh 11
Hanoi 11
Monmouth Junction 11
Totale 9.925
Nome #
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions 358
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 265
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 256
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 201
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 177
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. 150
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions. 148
Imaging of gynecological disease: clinical and ultrasound characteristics of uterine sarcomas 147
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 145
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 144
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology. 137
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 135
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 134
A case of isolated ovarian recurrence from vulvar carcinoma. 133
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 128
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 123
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 121
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 121
Application of liquid-based cytology to fine-needle aspiration biopsies of the thyroid gland 119
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 119
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial 117
Should a renal biopsy be performed at the first relapse of 'clinical nephrotic syndrome'? 116
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 116
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 115
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 115
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 115
[Laparoscopic diagnosis of peritoneal endometriosis] 114
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 114
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 111
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 110
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 108
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 108
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 107
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 105
Placental and infant metastasis of maternal melanoma: A new case. 105
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 104
Synchronous primary cancers of the endometrium and ovary versus endometrial cancer with ovarian metastasis: a single institution retrospective observational study 104
Aymptomatic intrathyroidal parathyroid adenoma: case report and differential diagnosis with thyroid neoplasms 103
A) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation 103
Placental and infant metastasis of maternal melanoma: a new case. 103
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 103
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 101
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 101
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 100
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 100
Thyroid fine-needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results 99
RNA (E6/E7) versus DNA (E6/E7) assays for risk evaluation in women infected with Human Papillomavirus (HPV) 99
Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? 99
Simultaneous ovarian and endometrial osseous metaplasia: a case report 97
Placental and infant metastasis of maternal melanoma: A new case. 96
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 95
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study 95
Management of adnexal masses with unexpected intracystic vegetation detected during laparoscopy. 95
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 95
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications 95
Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases 94
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 94
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 93
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 91
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer 91
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 90
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 90
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 88
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 88
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 87
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 87
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components 87
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: An observational study 87
The role of HPV detection and typing in diagnosis of pulmonary metastatic squamous cell carcinoma of the uterine cervix 86
Sexual dimorphism in medulloblastoma features 86
Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. 85
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 85
Morphology and immunophenotyping of a monolateral ovotestis in a 46,XderY/45,X mosaic individual with ambiguous genitalia 83
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 83
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 83
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 82
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 82
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis 81
Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors 81
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 80
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 79
Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. 78
Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size 78
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 78
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. 78
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 78
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 77
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 77
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 77
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 77
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: An analysis of 63 patients 76
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 76
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 75
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 75
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 75
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 75
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 73
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 73
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 73
Totale 10.679
Categoria #
all - tutte 96.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 0 0 0 0 0 0 125
2020/20211.323 65 111 51 151 188 67 145 23 130 128 216 48
2021/20222.006 144 112 38 196 101 66 47 318 87 108 351 438
2022/20234.721 572 652 346 712 246 610 290 403 570 60 173 87
2023/20242.389 94 681 77 129 82 349 139 99 49 136 297 257
2024/20254.520 77 129 376 206 403 226 244 221 711 670 1.180 77
Totale 19.286